Review of quercetin in metabolic diseases shows promise but lacks clinical validation.
Review suggests quercetin may have multiple beneficial effects on metabolic conditions
This review evaluates quercetin for conditions including diabetes, obesity, and gout. While the medication demonstrates favorable human tole…
A natural compound found in fruits and vegetables shows promise for managing type 2 diabetes, obesity, and fatty liver disease, though human…
In Silico Modeling Predicts Fezolinetant Hepatotoxicity Risk in MAFLD Population
Could a menopause drug harm the liver? A computer model offers clues.
Quantitative systems toxicology modeling simulated fezolinetant hepatotoxicity in virtual populations. The model predicted no ALT elevations…
A computer model predicts a menopause drug might cause rare liver injury in people with fatty liver disease, but higher doses could be safer…